Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo ; volume:14 ; number:1 ; day:28 ; month:2 ; year:2012 ; pages:1-14 ; date:2.2012
Breast cancer research ; 14, Heft 1 (28.2.2012), 1-14, 2.2012
- Urheber
-
Lahlou, Hicham
- Beteiligte Personen und Organisationen
-
Sanguin-Gendreau, Virginie
Frame, Margaret C.
Muller, William J.
SpringerLink (Online service)
- DOI
-
10.1186/bcr3131
- URN
-
urn:nbn:de:1111-2016032414176
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lahlou, Hicham
- Sanguin-Gendreau, Virginie
- Frame, Margaret C.
- Muller, William J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation
ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
ErbB2 signaling at the crossing between heart failure and cancer
Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation
ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
ErbB2 signaling at the crossing between heart failure and cancer
Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation
ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
ErbB2 signaling at the crossing between heart failure and cancer